comparemela.com

Latest Breaking News On - Lipocine inc - Page 1 : comparemela.com

Lipocine (NASDAQ:LPCN) Shares Pass Above 50-Day Moving Average of $5.03

Lipocine Inc. (NASDAQ:LPCN – Get Free Report) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $5.03 and traded as high as $6.59. Lipocine shares last traded at $6.38, with a volume of 31,513 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com […]

Nasdaq
Lipocine-company-profile
Lipocine-inc
Get-free-report
Lipocine-daily

Lipocine (NASDAQ:LPCN) Receives New Coverage from Analysts at StockNews.com

Lipocine (NASDAQ:LPCN) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine-company-profile
Lipocine-inc
Free-report
Get-free-report
Lipocine-daily

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine-inc
Free-report
Stock-down
Get-free-report
Lipocine-daily

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance LPCN opened at $4.80 on Friday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week high of $7.15. […]

Lipocine-inc
Free-report
Get-free-report
Lipocine-daily
Lipocine
Nasdaq-lpcn
Lpcn
Medical
Initiated-coverage
Stocknews-com

Short Interest in Lipocine Inc. (NASDAQ:LPCN) Increases By 155.6%

Lipocine Inc. (NASDAQ:LPCN – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 278,400 shares, an increase of 155.6% from the March 31st total of 108,900 shares. Currently, 5.4% of the company’s shares are sold short. Based […]

Nasdaq
Lipocine-inc
Lipocine-company-profile
Get-free-report
Lipocine-daily

vimarsana © 2020. All Rights Reserved.